NeuroPace, Inc. (NPCE)
NPCE Stock Price Chart
Explore NeuroPace, Inc. interactive price chart. Choose custom timeframes to analyze NPCE price movements and trends.
NPCE Company Profile
Discover essential business fundamentals and corporate details for NeuroPace, Inc. (NPCE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
22 Apr 2021
Employees
184.00
Website
https://www.neuropace.comCEO
Joel D. Becker
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
NPCE Financial Timeline
Browse a chronological timeline of NeuroPace, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Mar 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.20, while revenue estimate is $24.63M.
Earnings released on 12 Aug 2025
EPS came in at -$0.26 falling short of the estimated -$0.24 by -8.33%, while revenue for the quarter reached $23.52M , missing expectations by -3.74%.
Earnings released on 13 May 2025
EPS came in at -$0.21 surpassing the estimated -$0.26 by +19.23%, while revenue for the quarter reached $22.52M , missing expectations by -0.82%.
Earnings released on 4 Mar 2025
EPS came in at -$0.18 surpassing the estimated -$0.25 by +28.00%, while revenue for the quarter reached $21.47M , missing expectations by -0.44%.
Earnings released on 12 Nov 2024
EPS came in at -$0.19 surpassing the estimated -$0.26 by +26.92%, while revenue for the quarter reached $21.06M , beating expectations by +0.72%.
Earnings released on 13 Aug 2024
EPS came in at -$0.26 surpassing the estimated -$0.29 by +10.34%, while revenue for the quarter reached $19.26M , beating expectations by +5.22%.
Earnings released on 8 May 2024
EPS came in at -$0.32 matching the estimated -$0.32, while revenue for the quarter reached $18.12M , beating expectations by +4.76%.
Earnings released on 5 Mar 2024
EPS came in at -$0.23 surpassing the estimated -$0.33 by +30.30%, while revenue for the quarter reached $18.01M , beating expectations by +3.16%.
Earnings released on 6 Nov 2023
EPS came in at -$0.28 surpassing the estimated -$0.39 by +28.21%, while revenue for the quarter reached $16.43M , beating expectations by +4.03%.
Earnings released on 8 Aug 2023
EPS came in at -$0.36 surpassing the estimated -$0.47 by +23.40%, while revenue for the quarter reached $16.51M , beating expectations by +30.82%.
Earnings released on 4 May 2023
EPS came in at -$0.41 surpassing the estimated -$0.46 by +10.87%, while revenue for the quarter reached $14.47M , beating expectations by +18.92%.
Earnings released on 2 Mar 2023
EPS came in at -$0.45 surpassing the estimated -$0.49 by +8.16%, while revenue for the quarter reached $12.79M , beating expectations by +5.09%.
Earnings released on 8 Nov 2022
EPS came in at -$0.48 surpassing the estimated -$0.52 by +7.69%, while revenue for the quarter reached $11.16M , beating expectations by +12.70%.
Earnings released on 11 Aug 2022
EPS came in at -$0.52 falling short of the estimated -$0.44 by -18.18%, while revenue for the quarter reached $10.20M , missing expectations by -7.94%.
Earnings released on 12 May 2022
EPS came in at -$0.47 falling short of the estimated -$0.46 by -2.17%, while revenue for the quarter reached $11.37M , beating expectations by +6.86%.
Earnings released on 10 Mar 2022
EPS came in at -$0.44 falling short of the estimated -$0.33 by -33.33%, while revenue for the quarter reached $11.00M , missing expectations by -0.03%.
Earnings released on 10 Nov 2021
EPS came in at -$0.34 falling short of the estimated -$0.30 by -13.33%, while revenue for the quarter reached $10.34M , beating expectations by +15.38%.
Earnings released on 12 Aug 2021
EPS came in at -$0.36 surpassing the estimated -$0.39 by +7.69%, while revenue for the quarter reached $12.63M , beating expectations by +11.77%.
Earnings released on 3 Jun 2021
EPS came in at -$21.21 falling short of the estimated -$0.25 by -8.38K%, while revenue for the quarter reached $11.22M .
Earnings released on 24 Mar 2021
EPS came in at -$0.37 , while revenue for the quarter reached $12.77M .
Earnings released on 31 Dec 2020
EPS came in at -$0.42 , while revenue for the quarter reached $10.75M .
NPCE Stock Performance
Access detailed NPCE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.